Skip navigation
Home
About Us
Finance
Life Sciences
Technology
Contact
All
TVM Capital News
Life Sciences News
Technology News
TVM Capital
About Us
TVM Capital is a global venture firm with a 25 year operating track record. From our start in the early eighties when we invested in a broad range of growth companies across a multitude of industry sectors …
→
Learn more…
Life Sciences
The TVM Capital Life Science Team is a leader in biopharmaceutical industry venture and growth capital in Europe, with strong operations in the U.S. and a growing presence in Asia. We build on the …
→
Learn more…
Technology
TVM Capital’s Technology Team invests in promising businesses with a focus in information technology, communications and clean technology. Specifically, TVM Capital possesses expertise that enables …
→
Learn more…
Recent News
Life Sciences Events
Technology Events
Spotlight
07/21/2008
Dr Flemming Ornskov Nominated for Election as Chairman of the Supervisory Board of Evotec
07/17/2008
MediGene exercises option for Anti-L1 Monoclonal Antibody and continues collaboration...
07/17/2008
EpiCept and GNI Partner to Develop Anti-Viral Hepatitis Drug in Asia
07/17/2008
ReVolt Technology, Ltd. Selected by AlwaysOn as an AO Global 250 Winner
07/16/2008
EpiCept Announces Pricing of Public Offering
07/16/2008
Ark Therapeutics - EMEA Gene Therapy Working Party gives positive feedback on EG013 for...
Barcelona, Spain — July 18-22
ESOF 2008
Taipei, Taiwan — July 22-23
BioBusiness Asia 2008
Paris, France — October 6-7
TechTransfer Summit at EuroBio 2008
Zurich, Switzerland — September 22-23
European Energy Venture Fair 2008
Linz, Austria — September 29
Cleantech Venture Forum
Brussels, Belgium — October 8-10
"The SmartGrids Revolution - make it happen"
TVM Capital Technology — March 2008
Portfolio Spotlight on Ubidyne
TVM Capital Life Sciences — July 2008
Spezialisiertes Wachstumskapital